S'abonner

Clinical trial of an educational intervention to achieve recommended cholesterol levels in patients with coronary artery disease - 26/08/11

Doi : 10.1016/j.ahj.2003.06.003 
Judith H Lichtman, PhD a, b, Joan Amatruda, RN c, Shlomit Yaari, MS a, Susan Cheng, BA a, Grace L Smith, MPH a, Jennifer A Mattera, MPH a, Sarah A Roumanis, RN a, Yun Wang, MS a, Martha J Radford, MD c, d, Harlan M Krumholz, MD a, c, e,
a Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, Conn, USA 
b Section of Chronic Disease Epidemiology, Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, Conn, USA 
c Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, Conn, USA 
d Center for Outcomes Research and Evaluation, Yale-New Haven Health, New Haven, Conn, USA 
e Section of Health Policy and Administration, Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, Conn, USA 

*Reprint requests: Harlan M. Krumholz, MD, Yale University School of Medicine, PO Box 208025, New Haven, CT 06520-8025, USA.

Abstract

Background

Despite national efforts to improve cholesterol management for patients with coronary artery disease, many patients are not reaching recommended cholesterol target levels. We sought to determine whether a nurse-based educational intervention, designed to educate patients with confirmed coronary artery disease about personal low-density lipoprotein (LDL) cholesterol target levels and encourage partnership with physicians, could increase adherence with National Cholesterol Education Program target levels (LDL cholesterol level ≤100 mg/dL).

Methods

Patients hospitalized with confirmed coronary artery disease were randomized to undergo a nurse-based educational intervention (375 patients) or usual care (381 patients) for a 12-month period after hospitalization. The primary outcome was the proportion of patients at the LDL cholesterol target level 1 year after hospitalization. The secondary outcome was the proportion of patients with accurate knowledge of LDL cholesterol target levels.

Results

The groups were similar at baseline in demographic and clinical characteristics, percent at LDL cholesterol target level (43.9% and 41.1%, respectively), and percent with knowledge of LDL cholesterol target levels (both 5%). The proportion of patients at LDL cholesterol target levels at 1 year did not differ between the intervention (70.2%) and usual care group (67.4%, P = .46). At the conclusion of the trial, patient knowledge about LDL cholesterol target level was higher for the intervention group than the usual care group (19.6% and 6.7%, respectively, P = .001), but this was not associated with improved cholesterol management.

Conclusions

Our nurse-based educational intervention did not result in a significant increase in the proportion of patients who reached target LDL cholesterol levels 1 year after hospitalization. Although the intervention improved patient knowledge of LDL cholesterol target levels, overall rates of LDL cholesterol knowledge remained low, and it was not associated with improved cholesterol management.

Le texte complet de cet article est disponible en PDF.

Plan


 Supported by a grant from Pfizer. Dr Lichtman is a Goddess Fund Career Development Scholar.


© 2004  Mosby, Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 147 - N° 3

P. 522-528 - mars 2004 Retour au numéro
Article précédent Article précédent
  • Influence of endothelial nitric oxide synthase gene polymorphisms (G894T, 4a4b, T-786C) and hyperhomocysteinemia on the predisposition to acute coronary syndromes
  • Cinzia Fatini, Francesco Sofi, Elena Sticchi, Francesca Gensini, Anna Maria Gori, Sandra Fedi, Ilaria Lapini, Carlo Rostagno, Marco Comeglio, Daria Brogi, Gianfranco Gensini, Rosanna Abbate
| Article suivant Article suivant
  • Lifestyle determinants of high-density lipoprotein cholesterol: the National Heart, Lung, and Blood Institute Family Heart Study
  • R.Curtis Ellison, Yuqing Zhang, Muhammad Mustafa Qureshi, Sarah Knox, Donna K Arnett, Michael A Province, Investigators of the NHLBI Family Heart Study

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2025 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.